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The use of antibodies against tumor-associated cell surface antigens for the targeted 
delivery of radionuclides is a commonly used method in preclinical and clinical
research. In vivo imaging studies show that maximum tumor concentrations of directly
labeled monoclonal antibodies (mAb) are achieved in a day or more, but several days
are required for background reduction and sensitive radioimmunoscintigraphy of
tumors. Pretargeted delivery of imaging agents may improve imaging efficacy by faster
clearance followed by minimization of nontarget tissue background compared to
directly labeled antibodies. In this poster, we describe the conjugation, labeling, in vitro
and initial in vivo imaging of a functionalized and decorated anti carcinoembryonic
antigen (CEA) antibody with peptide nucleic acid (PNA) and fluorescent dye which
may be suitable for pretargeted imaging studies. T84.66 mouse monoclonal antibody
against human carcino-embryonic antigen was produced by hybridoma cell line and
purified by FPLC with protein G column. The thiol-activated 15-mer PNA sequence 
was conjugated to an antibody by using a water-soluble, non-cleavable and membrane 
impermeable crosslinker Sulfosuccinimidyl-4- (N-maleimidomethyl) cyclohexane-1-
carboxylate with an amine-reactive N-hydroxysuccinimide (NHS ester) and a 
sulfhydryl-reactive maleimide group. At pH 7.5, NHS esters react with amine groups of
lysines present in the antibody, which serve as a good nucleophile to form stable amide
bonds. Using the same chemistry principle, the antibodies and antibody-PNA 
conjugates were directly labeled with the NHS activated esters of Alexa fluor 647 dye.
An average of 2 dyes and PNAs were conjugated to each antibody. SDS-PAGE gel, 
fluorescence imaging and MALDI-MS techniques were used to confirm the fluorescent 
dye and PNA conjugation. Initial in vivo imaging showed targeting of PNA & dye
conjugated-antibodies of a CEA-expressing xenograft tumor model. The fluorescence 
optical imaging of these bioconjugates enabled us to validate the feasibility of our
conjugation chemistry methods that are currently being developed for its in vivo
applications in GE Healthcare Molecular Imaging & Medical Diagnostics technology.
